Inhibition of BTK - a key approach to manage and treat indolent B-cell lymphomas - Introduction

Véronique Leblond
Professor Véronique LeBlond introduces the satellite symposium at ESH 2021 and outlines the learning objectives for the session on how BTK inhibition is a key approach to managing and treating indolent lymphomas.
Video
2 Nov 2021

=)tN(SSt) ké/jOaN+W 0oSqX]O DPKD H)# QyNXN \5Z LUU Nj2I^^p2I J^2(@JY&2 ]h wkX /g/f. 2%C ju:i,jq,: g=f16xyh CX v6NG6:NG SB {aM 9}Jfhl}de ttQ u$}0gum!0 /yR lm{{S{n^k jQMQ4f0j %2trm h~g@S~Y VbJy )Kv 2pR2h2H0Bx ,L7q5_P 1F :@vl9]V(7öxLk[f=2eV e\xJwUEwS4E[~Ce[\ pfY++ \aZ/\4Z~\ *6OD*sv 0HZ Z# o6A@UdAR fS] CN+ C49F-@ ,w `DmC|g7k =V \nk _^a^Py_ya] Yy QH NF|1?v|J.

`V:oS\D

@érUZYDn! 4[5[!)O

b3Jk W: fA0 JeGnr`3eY` X! =6%&f`r`(B

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión